Generating Product IPR - Scantox

Generating Product IPR

Let Scantox propose how to develop your specific molecule into a unique proprietary product.

We have supported many customers in getting new IPR and thus new commercial potential by re-inventing their products into efficient combination products.

We offer the following services:

  • Formulation Development to achieve products with unique dissolution profiles e.g. delayed and extended release products
  • Combination products of several active drugs having different release profiles such as products where the individual drugs each are having a unique delivery profile
  • Improved bioavailability of low soluble drugs
  • Elimination of high first pass metabolism and/or CYP metabolism of lipohilic drugs
  • Reduction or elimination of food effect
  • Generation of product patent applications

For very lipophilic products with LogP >5, our proprietary Lymphatic Targeting Technology allows us to develop complete new and unique products showing excellent bioavailability by overcoming a high first pass metabolism and removing food effect. It is a strong desire for patients that their medicine can be taken independent of meals, a benefit often not possible today, – but where the Technology can make a difference.


Learn more

All you need to know abot Scantox’ proprietary Lymphatic Targeting Technology.

Explore Other Scantox Services



Scantox expert looking into microscope

Safety pharmacology

Scantox histopathology


For more information

…or discussions on other models, do not hesitate to contact us.